Related Experiment Videos
Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism
T V Wade1, D S Rothblat, J S Schneider
1Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, 1020 Locust Street, JAH 521, Philadelphia, PA 19107, USA.
Abstract:
Striatal dopamine (DA) D3 receptor density (measured by quantitative receptor autoradiography) and mRNA expression (measured by reverse transcriptase-polymerase chain reaction) were analyzed in cats symptomatic for and recovered from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. In symptomatic cats, D3 receptor density was significantly decreased in all regions of the caudate nucleus (CD) (66--77%), the nucleus accumbens (NACC) (52--83%) and the islands of calleja (IC) (67%), all of which returned to normal values in recovered cats. In contrast, D3 receptor mRNA expression was slightly elevated in symptomatic cats, and significantly increased above normal in recovered cats (45% increase in the CD and 91% in the NACC). Thus, reduction of parkinsonian signs was related to normalization of striatal D3 receptor number. These alterations in D3 receptor expression may play an important role in the recovery process observed in this model of parkinsonism.
Insights
Dopamine D3 receptor density normalized in cats recovering from parkinsonism. This normalization correlated with symptom reduction, suggesting a key role for D3 receptors in the recovery process.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Parkinsonism is a neurodegenerative disorder characterized by motor deficits.
- The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model in cats mimics key features of Parkinson's disease.
- Dopamine D3 receptors are implicated in motor control and reward pathways.
Purpose of the Study:
- To investigate the role of striatal dopamine D3 receptors in MPTP-induced parkinsonism and recovery.
- To correlate changes in D3 receptor density and mRNA expression with behavioral recovery.
Main Methods:
- Quantitative receptor autoradiography to measure D3 receptor density.
- Reverse transcriptase-polymerase chain reaction to assess D3 receptor mRNA expression.
- Behavioral assessment of parkinsonian signs in cats.
Main Results:
- Symptomatic cats showed significantly decreased striatal D3 receptor density in the caudate nucleus, nucleus accumbens, and islands of Calleja.
- D3 receptor density returned to normal levels in recovered cats.
- D3 receptor mRNA expression was elevated in symptomatic cats and further increased in recovered cats.
Conclusions:
- Normalization of striatal D3 receptor density is associated with the reduction of parkinsonian signs.
- Altered D3 receptor expression, particularly mRNA levels, may be crucial for the recovery process in this parkinsonism model.
- Dopamine D3 receptors represent a potential therapeutic target for promoting recovery from parkinsonism.